Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc.

Market Analysis and Insights: Global Generic Injectables Market
The global Generic Injectables market is valued at US$ 25420 million in 2019. The market size will reach US$ 36570 million by the end of 2026, growing at a CAGR of 5.3% during 2021-2026.

Global Generic Injectables Scope and Market Size
Generic Injectables market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Generic Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Large Molecule Injectables (Biosimilars)
Small Molecule Injectables

Segment by Application
Oncology
Infectious Diseases
Cardiology
Diabetes
Immunology
Others

By Company
Pfizer
Sandoz International
Baxter
Fresenius
Mylan
Teva Pharmaceutical
Hikma Pharmaceuticals
Lupin Pharmaceuticals
Sanofi
Biocon

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia